Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Proteomics International Laboratories.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Neuren to start Phase 2 trial soon; Proteomics expands footprint in South America
Health & Biotech
ASX Health Stocks: Mesoblast partners up for pivotal trial, Alterity in $4.8 million cap raise
Health & Biotech
ASX Biotech September Winners: Healthcare down 5pc, but experts say it’s still best sector in a recession
News
In Case You Missed It: Medicare milestone and provisional ports approval
News
ASX Health Stocks: Proteomics soars 13pc after US sets reimbursement price for PromarkerD
News
Top 10 at 11: It’s a mixed up kinda morning, but we’re moving in the right direction… for now
Health & Biotech
2023 ASX biotech darling Neuren among sector stocks with upcoming catalysts
Health & Biotech
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
Health & Biotech
ASX Health Stocks: Genetic Signatures jumps 20pc on FDA update, Proteomics reveals new patent in Japan
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as Proteomics inks Sonic deal
News
CLOSING BELL: Smiles all round as the ASX holds onto early gains to finish 0.78% heavier
Health & Biotech
ScoPo’s (he’s back) Powerplays: ASX health stocks fall, Volpara ‘elephants’ strategy pays off
Health & Biotech
ASX Health Stocks: Proteomics’ blood test PromarkerD effective with diabetes drug Canagliflozin
News
Market Highlights: Crude prices tumble 5pc; and 5 ASX small caps to watch on Wednesday
Health & Biotech
Q+A: Proteomics MD Richard Lipscombe on its potential US breakthrough with Sonic Healthcare
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines update
News
